Avandia Lawsuit Filed in Dallas Federal Court Against GlaxoSmithKline
A Dallas man died of a heart attack on May 21, 2007, the very same day that
an article in the New England Journal of Medicine exposed the heart
attack risks related to Avandia, according the the Southeast Texas
Record.
Lany Stanford, a type 2 diabetic, took the popular diabetes
drug to help regulate his insulin. According to the Record, Stanford's
family doesn't believe it was a coincidence that he died the same day the study
was published.
Family members have filed a wrongful death suit against
the maker of Avandia, GlaxoSmithKline. The are alleging that the pharmaceutical
giant "unfairly" convinced the Food and Drug Administration to approve Avandia,
and then went on a "marketing assault" with a drug GSK officials knew was
harmful.
If you or a loved one has suffered cardiac complications after
ingesting Avandia, you deserve the guidance of a knowledgeable drug attorney.
Get a free case review by filling out the form below.
see also:
Negligence at Issue
Avandia Cases: Wrongful Death Lawsuit Filed in Texas Against GlaxoAvandia Cases Grow; Wrongful Death Suit Alleges Glaxo was Negligent
Second Black Box?
FDA: Black Box Warning Label Decision Pending on Avandia Diabetes DrugFDA to Announce Decision on Black Box for Avandia Soon--Lawsuit Info
News & Warnings
Avandia Breaking News: Glaxo Warned in 2001 about Misleading MarketingBloomberg News: FDA Warned Glaxo about Avandia Marketing in 2001


